Myriad Genetics | MYGN - Fremdkapital

Aktienkurs
4.29
Täglich Wechseln
-0.33 -7.14%
Monatlich
-14.37%
Jährlich
-51.69%
Q1 Prognose
4.54




Fremdkapital Veränderung Datum
Agilent USD 3.05B 0 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Bio-Rad Laboratories USD 1.2B 300K 2025-12
Bruker USD 1.85B 131.7M 2025-12
Danaher USD 18.42B 1.58B 2025-12
Hologic USD 2.5B 2.1M 2025-12
Illumina USD 1.49B 496M 2025-12
J&J USD 39.44B 30M 2025-12
Mettler Toledo International USD 2.09B 58.01M 2025-12
Myriad Genetics USD 119.9M 400K 2025-12
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Quest Diagnostics USD 5.17B 4M 2025-12
Quidel USD 2.47B 2.47B 2025-12
Repligen USD 542.21M 4.29M 2025-12
Revvity USD 2.63B 543K 2025-12
Standard Biotools USD 299K 0 2025-12
Thermo Fisher Scientific USD 35.85B 4B 2025-12
Veracyte USD 0 0 2025-03
Waters USD 1.41B 460.24M 2025-12